Literature DB >> 18394757

Ultrastructures and strain comparison of under-glycosylated scrapie prion fibrils.

Valerie L Sim1, Byron Caughey.   

Abstract

Prions, composed primarily of misfolded, often fibrillar, polymers of prion protein, have poorly understood structures. Heavy surface glycosylation may obscure visualization of their fibrillar cores, so we purified severely under-glycosylated prion protein fibrils from scrapie-infected transgenic mice expressing anchorless prion protein. Using electron and atomic force microscopy, we obtained dimensions and morphological information about prion protein core protofilaments which variably intertwined to form scrapie fibrils. Occasional isolated protofilaments were observed, suggesting that the lateral association of protofilaments is neither essential nor invariant in prion protein polymerization. Strain comparisons suggested basic structural differences; ME7 and 22L fibrils contained thinner protofilaments, 22L fibrils preferred left-handed twists, and 22L fibril periodicities averaged 106nm per half-turn, compared with 64 and 66nm for RML and ME7 fibrils, respectively. The strains displayed overlapping fibril morphologies, providing evidence that prion fibril morphology is influenced, but not dictated, by strain-dependent differences in protofilament structure. These measurements of the amyloid core of scrapie fibrils should aid development of models of prion structure and strain determination.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18394757     DOI: 10.1016/j.neurobiolaging.2008.02.016

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  44 in total

Review 1.  Techniques to elucidate the conformation of prions.

Authors:  Martin L Daus
Journal:  World J Biol Chem       Date:  2015-08-26

Review 2.  Prions and the potential transmissibility of protein misfolding diseases.

Authors:  Allison Kraus; Bradley R Groveman; Byron Caughey
Journal:  Annu Rev Microbiol       Date:  2013-06-28       Impact factor: 15.500

3.  Dissociation of recombinant prion protein fibrils into short protofilaments: implications for the endocytic pathway and involvement of the N-terminal domain.

Authors:  Xu Qi; Roger A Moore; Michele A McGuirl
Journal:  Biochemistry       Date:  2012-05-23       Impact factor: 3.162

Review 4.  High-resolution structure of infectious prion protein: the final frontier.

Authors:  Rodrigo Diaz-Espinoza; Claudio Soto
Journal:  Nat Struct Mol Biol       Date:  2012-04-04       Impact factor: 15.369

5.  Parallel in-register intermolecular β-sheet architectures for prion-seeded prion protein (PrP) amyloids.

Authors:  Bradley R Groveman; Michael A Dolan; Lara M Taubner; Allison Kraus; Reed B Wickner; Byron Caughey
Journal:  J Biol Chem       Date:  2014-07-15       Impact factor: 5.157

6.  Parameters that affect macromolecular self-assembly of prion protein.

Authors:  Seon-Gu Kim; Hye-Mi Lee; Chongsuk Ryou
Journal:  Protein J       Date:  2014-06       Impact factor: 2.371

Review 7.  Getting a grip on prions: oligomers, amyloids, and pathological membrane interactions.

Authors:  Byron Caughey; Gerald S Baron; Bruce Chesebro; Martin Jeffrey
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

Review 8.  Hydrogen-exchange mass spectrometry for the study of intrinsic disorder in proteins.

Authors:  Deepa Balasubramaniam; Elizabeth A Komives
Journal:  Biochim Biophys Acta       Date:  2012-10-22

9.  The physical relationship between infectivity and prion protein aggregates is strain-dependent.

Authors:  Philippe Tixador; Laëtitia Herzog; Fabienne Reine; Emilie Jaumain; Jérôme Chapuis; Annick Le Dur; Hubert Laude; Vincent Béringue
Journal:  PLoS Pathog       Date:  2010-04-15       Impact factor: 6.823

10.  The polybasic N-terminal region of the prion protein controls the physical properties of both the cellular and fibrillar forms of PrP.

Authors:  Valeriy G Ostapchenko; Natallia Makarava; Regina Savtchenko; Ilia V Baskakov
Journal:  J Mol Biol       Date:  2008-09-04       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.